Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Denschlag

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Gynecologic Oncology|February 22, 2005
Evaluation of patients after extraperitoneal lymph node dissection for cervical cancerD Denschlag, B Gabriel, C Mueller-Lantzsch, et al.
Anticancer Research|October 15, 2010
Evaluation of FDG-PET for detecting lymph node metastasis in uterine corpus cancerM Klar, P T Meyer, K Hancke, et al.
Molecular Human Reproduction|February 26, 2004
The size of a microsatellite polymorphism of the haem oxygenase 1 gene is associated with idiopathic recurrent miscarriageD Denschlag, R Marculescu, G Unfried, et al.
Geburtshilfe Und Frauenheilkunde|March 24, 2015
Surgical Methods for the Treatment of Uterine Fibroids - Risk of Uterine Sarcoma and Problems of Morcellation: Position Paper of the DGGGM W Beckmann, I Juhasz-Böss, D Denschlag, et al.
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)D Denschlag, F C Thiel, S Ackermann, et al.
Geburtshilfe Und Frauenheilkunde|January 13, 2016
Erratum: Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)D Denschlag, F C Thiel, S Ackermann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2023
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trialI Ray-Coquard, A Leary, S Pignata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2024
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trialP Harter, C Marth, M-A Mouret-Reynier, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Gynecologic Oncology|February 22, 2005
Evaluation of patients after extraperitoneal lymph node dissection for cervical cancerD Denschlag, B Gabriel, C Mueller-Lantzsch, et al.
Anticancer Research|October 15, 2010
Evaluation of FDG-PET for detecting lymph node metastasis in uterine corpus cancerM Klar, P T Meyer, K Hancke, et al.
Molecular Human Reproduction|February 26, 2004
The size of a microsatellite polymorphism of the haem oxygenase 1 gene is associated with idiopathic recurrent miscarriageD Denschlag, R Marculescu, G Unfried, et al.
Geburtshilfe Und Frauenheilkunde|March 24, 2015
Surgical Methods for the Treatment of Uterine Fibroids - Risk of Uterine Sarcoma and Problems of Morcellation: Position Paper of the DGGGM W Beckmann, I Juhasz-Böss, D Denschlag, et al.
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)D Denschlag, F C Thiel, S Ackermann, et al.
Geburtshilfe Und Frauenheilkunde|January 13, 2016
Erratum: Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)D Denschlag, F C Thiel, S Ackermann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2023
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trialI Ray-Coquard, A Leary, S Pignata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2024
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trialP Harter, C Marth, M-A Mouret-Reynier, et al.
Pageof 2